Cargando…
Cell Engineering and Molecular Pharming for Biopharmaceuticals
Biopharmaceuticals are often produced by recombinant E. coli or mammalian cell lines. This is usually achieved by the introduction of a gene or cDNA coding for the protein of interest into a well-characterized strain of producer cells. Naturally, each recombinant production system has its own unique...
Autores principales: | Abdullah, M.A, Rahmah, Anisa ur, Sinskey, A.J, Rha, C.K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers Ltd.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2709479/ https://www.ncbi.nlm.nih.gov/pubmed/19662143 http://dx.doi.org/10.2174/1874104500802010049 |
Ejemplares similares
-
Fat pharms.
por: Ma, M
Publicado: (1996) -
The technology of pharming
por: Rehbinder, Eckard, et al.
Publicado: (2009) -
Engineering the N-glycosylation pathway of Nicotiana tabacum for molecular pharming using CRISPR/Cas9
por: Göritzer, Kathrin, et al.
Publicado: (2022) -
Plant-based biopharmaceutical engineering
por: Eidenberger, Lukas, et al.
Publicado: (2023) -
Legal problems of pharming
por: Rehbinder, Eckard, et al.
Publicado: (2009)